Virotherapy - Cancer targeted pharmacology

Virotherapy - Cancer targeted pharmacology

Pokaži ostale verzije (1)

Building on their success in vaccination, many groups are now exploring the use of viruses as anticancer agents. In general, viral therapeutics provide the possibility to express anticancer proteins directly at the tumour site, decreasing exposure to normal tissue during delivery and maximising ther...

Bibliografski detalji
Glavni autori:	Tedcastle, A, Cawood, R, Di, Y, Fisher, K, Seymour, L
Format:	Journal article
Jezik:	English
Izdano:	2012

Slični predmeti

Virotherapy--cancer targeted pharmacology.
od: Tedcastle, A, i dr.
Izdano: (2012)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
od: Green, N, i dr.
Izdano: (2012)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
od: Bazan-Peregrino, M, i dr.
Izdano: (2008)

Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
od: Kueberuwa, G, i dr.
Izdano: (2011)

Combining virotherapy and angiotherapy for the treatment of breast cancer.
od: Bazan-Peregrino, M, i dr.
Izdano: (2013)

Combining virotherapy and angiotherapy for the treatment of breast cancer
od: Bazan-Peregrino, M, i dr.
Izdano: (2013)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
od: Morrison, J, i dr.
Izdano: (2008)

Oncolytic virotherapy: combining first-rate science with an unmet clinical need.
od: Seymour, L
Izdano: (2011)

Virotherapy in Head and Neck Cancer
od: Zhan Wang
Izdano: (2024-03-01)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
od: Tedcastle, A, i dr.
Izdano: (2011)

Cavitation-enhanced tumour-targeting virotherapy by ultrasound
od: Mo, S
Izdano: (2013)

Oncolytic virotherapy targeting the IL15 pathway
od: So Young Yoo, i dr.
Izdano: (2023-12-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
od: Shyambabu Chaurasiya, i dr.
Izdano: (2021-04-01)

Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
od: Khandoker Usran Ferdous, i dr.
Izdano: (2024-07-01)

Modeling dynamics of cancer virotherapy with immune response
od: Salma M. Al-Tuwairqi, i dr.
Izdano: (2020-08-01)

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
od: Tedcastle, A, i dr.
Izdano: (2016)

Editorial: Oncolytic virotherapy
od: Ahmed Majeed Al-Shammari, i dr.
Izdano: (2023-11-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
od: Thoma, CMM
Izdano: (2011)

Lung cancer and oncolytic virotherapy——enemy's enemy
od: Zhang Li, i dr.
Izdano: (2023-01-01)

DNA-damaging cancer cells to improve virotherapy
od: Marc Garcia-Moure, i dr.
Izdano: (2022-12-01)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
od: Carlisle, R, i dr.
Izdano: (2013)

Oncolytic Virotherapy for Hematological Malignancies
od: Swarna Bais, i dr.
Izdano: (2012-01-01)

Mathematical modelling of oncolytic virotherapy
od: Shabala, A
Izdano: (2013)

Cellular carriers or free viruses?
od: Seymour, L, i dr.
Izdano: (2008)

Oncolytic virotherapy in head and neck cancer: A hope?
od: Vishnu Priya Veeraraghavan, i dr.
Izdano: (2024-03-01)

Oncolytic virotherapy in gastric cancer: Towards precision therapeutics
od: Muhammad Ikrama, i dr.
Izdano: (2024-04-01)

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
od: Lingjuan Chen, i dr.
Izdano: (2023-12-01)

Current perspectives of virotherapy as a cancer treatment strategy
od: Lyubov D. Vlasova
Izdano: (2024-12-01)

The combination therapy of oncolytic virotherapy
od: Yue Wang, i dr.
Izdano: (2024-04-01)

Syncytia Formation in Oncolytic Virotherapy
od: Chase Burton, i dr.
Izdano: (2019-12-01)

Progress of oncolytic virotherapy for neuroblastoma
od: Xiao-Tong Chen, i dr.
Izdano: (2022-11-01)

Delivery and Biosafety of Oncolytic Virotherapy
od: Lizhi Li, i dr.
Izdano: (2020-04-01)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
od: Muhammad Naveed, i dr.
Izdano: (2024-11-01)

Recombinant viral vaccines for cancer
od: Cawood, R, i dr.
Izdano: (2012)

Recombinant viral vaccines for cancer.
od: Cawood, R, i dr.
Izdano: (2012)

Gaining insights into virotherapy with canine models
od: Jacob L. Léger, i dr.
Izdano: (2023-12-01)

The Multifaceted Role of Macrophages in Oncolytic Virotherapy
od: Laura Hofman, i dr.
Izdano: (2021-08-01)

Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
od: Sarah Di Somma, i dr.
Izdano: (2021-09-01)

Current Development of Virotherapy in Breast Cancer: A Brief Review
od: Sasmana I., i dr.
Izdano: (2024-12-01)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
od: Amy Kwan, i dr.
Izdano: (2021-06-01)